LIPICURE 20

1. All Details: Specifications
Dosage Form: Film coated tablets.
Storage Conditions: Store below 25°C, protected from moisture.
Batch Number (B.No.): N2303084
Manufacturing Date (MFD.): NOV.2023
Expiry Date (EXP.): OCT.2026
Manufacturing License Number: Mfg. Lic. No.: M/717/2016
Maximum Retail Price (M.R.P.): Rs. 210.97 for 15 tablets (indicated as “M.R.P.Rs. 210.97 FOR 15 TABS. INCL. OF ALL TAXES” on both the packaging stamp and the white retail label sticker).
Retail Sticker Identifiers: N2303084, 10/26, Lipicure 20 mg Tablet, 9990102474653, SS007.
2. General
Brand: Lipicure-20 (also printed in Devanagari script as लिपिंक्योर-२०).
Generic Name: Atorvastatin Calcium Tablets IP 20 mg
Quantity: 15 Tablets per blister strip (indicated by “FOR 15 TABS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the red statutory Schedule H prescription caution box).
Form Factor: Blister strip containing solid oral film-coated tablets.
Maximum Shelf Life: 2 years and 11 months (from November 2023 to October 2026).
Food Preference / FSSAI: Not Applicable. This is an allopathic therapeutic drug used for cardiovascular and metabolic management, not a food product or commercial dietary supplement. It falls entirely under national drug control frameworks instead of the FSSAI food authority, and it does not feature vegetarian or non-vegetarian markings.
3. Product Details: Ingredients
Each film coated tablet contains:
Atorvastatin Calcium IP equivalent to Atorvastatin: 20 mg
Excipients: Q.S. (Quantity Sufficient)
Colour: Titanium Dioxide IP
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Label:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: Lipicure-20 is an oral lipid-lowering medication belonging to the statin (HMG-CoA reductase inhibitor) class of drugs. Its active component, Atorvastatin, works by blocking a specific hepatic enzyme needed to synthesize cholesterol, thereby significantly lowering low-density lipoprotein (LDL) “bad” cholesterol and triglycerides while raising high-density lipoprotein (HDL) “good” cholesterol. It is standardly prescribed under strict medical supervision to manage dyslipidemia and reduce the risk of cardiovascular events like heart attacks or strokes.
Visual Presentation: The packaging consists of a golden-backed metallic foil blister layout explicitly engineered to safeguard the integrity of the tablets against light and humidity. It features a scannable authentication QR code labeled “Scan to know more about dyslipidemia,” parallel red hazard warning lines, distinct dark typography for high scannability, and corporate branding from Intas Pharmaceuticals.
6. Manufacturer Information
Manufactured by: INTAS PHARMACEUTICALS LTD.
Factory Address: Samardung Road, Kabrey Block, Namthang Elaka, Sikkim-737132, INDIA.
7. Marketed By
Marketed by: INTAS PHARMACEUTICALS LTD.